Tirzepatide vs Mounjaro: Same Drug, Different Names?

Q: What is the difference between Mounjaro and Zepbound?

Both Mounjaro and Zepbound contain tirzepatide. Mounjaro is FDA approved for type 2 diabetes. Zepbound is FDA approved for obesity and weight management. The active drug is identical; the indication and approved population differ.

Built by medical professionals, gym rats, and experienced biohackers

Yes, tirzepatide and Mounjaro are the same drug. Mounjaro is the brand name for tirzepatide approved for type 2 diabetes, and Zepbound is the brand name for the same drug approved for weight loss. But tirzepatide itself is genuinely different from semaglutide, and that distinction is worth understanding.

Quick Answer: What Is the Real Difference?

Tirzepatide is the generic name of the active molecule. This is what you see in scientific papers and clinical trials.

Mounjaro is the brand name Eli Lilly uses to sell tirzepatide for type 2 diabetes.

Zepbound is the brand name Eli Lilly uses to sell the same tirzepatide for weight loss in people with obesity.

Verdict: There is no chemical difference between Mounjaro and Zepbound. The molecule is identical. The difference is the approved indication, the population studied, and the brand name on the box.

What Is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist.

That means it activates two hormone receptors at the same time: the GIP receptor and the GLP-1 receptor. GLP-1 is the same pathway that semaglutide targets. GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that works alongside GLP-1.

By hitting both receptors, tirzepatide reduces appetite, slows stomach emptying, and helps the pancreas release insulin in response to food. The dual action appears to produce larger weight loss than a GLP-1 agonist alone .

What Is Mounjaro?

Mounjaro is the version of tirzepatide that Eli Lilly brought to market for type 2 diabetes.

The FDA approved Mounjaro in 2022 based on the SURPASS clinical trial program, which showed significant reductions in blood sugar (HbA1c) compared to placebo and other diabetes medications .

It is a once-weekly subcutaneous injection, starting at 2.5 mg per week and titrated up to a maximum of 15 mg per week .

How Do the Mounjaro and Zepbound Brands Differ?

Is the molecule different?

No. The active drug in both Mounjaro and Zepbound is tirzepatide. The molecular structure is identical.

What is each one approved for?

Mounjaro: FDA approved to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise .

Zepbound: FDA approved for long-term weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with at least one weight-related condition .

What are the typical doses?

Both start at 2.5 mg per week for the first four weeks.

Tirzepatide is then titrated up in 2.5 mg increments every four weeks as tolerated, reaching a maximum of 15 mg per week in both indications .

How much weight loss do trials show?

The SURMOUNT-1 trial, which studied Zepbound specifically for obesity, showed an average weight loss of around 20% of body weight at the highest dose over 72 weeks .

The SURPASS trials for Mounjaro showed HbA1c reductions as well as meaningful weight loss in people with type 2 diabetes .

How does tirzepatide compare to semaglutide on weight loss?

A head-to-head trial called SURMOUNT-5 compared tirzepatide to semaglutide in people with obesity but without type 2 diabetes. Tirzepatide produced greater average weight loss . Both drugs are effective; tirzepatide appears to be stronger on this metric.

Side-by-Side Comparison

	Mounjaro	Zepbound
Active drug	Tirzepatide	Tirzepatide
FDA approval	Type 2 diabetes	Obesity and weight management
Dosing range	2.5 to 15 mg/week	2.5 to 15 mg/week
Injection frequency	Once weekly	Once weekly
Key clinical trials	SURPASS series	SURMOUNT series
Common side effects	Nausea, diarrhea, vomiting	Nausea, diarrhea, vomiting

How Is Tirzepatide Different From Semaglutide?

This is the more interesting question.

Semaglutide (Ozempic, Wegovy) activates only the GLP-1 receptor. Tirzepatide activates both GLP-1 and GIP. Adding GIP activation seems to amplify the appetite-reducing effects and may improve fat metabolism in ways that single-target GLP-1 agonists do not .

These are genuinely different drugs with different mechanisms, not just different doses of the same thing.

Which Do People Pick, and When?

This is general guidance, not personalized medical advice.

People on Mounjaro typically have type 2 diabetes and are using tirzepatide as part of their blood sugar management, often alongside diet and exercise.

People on Zepbound typically have obesity or overweight with a related condition such as high blood pressure or sleep apnea, and are using tirzepatide specifically for weight management.

If your clinician offers both options, the choice often comes down to insurance coverage and which indication your insurance will approve.

Staying on top of a weekly injection schedule and titration steps is a lot to manage. DoseVault helps you log each dose, track side effects, and keep a clear record of where you are in your titration.

Frequently Asked Questions

Is tirzepatide the same as Mounjaro?

Yes. Mounjaro is the brand name for tirzepatide approved for type 2 diabetes. Tirzepatide is the generic name for the active molecule. Zepbound is another brand name for the same drug, approved for weight loss.

What is the difference between Mounjaro and Zepbound?

Both contain tirzepatide. Mounjaro is FDA approved for type 2 diabetes. Zepbound is FDA approved for obesity and weight management. The active drug is identical.

How does tirzepatide differ from semaglutide?

Semaglutide activates only the GLP-1 receptor. Tirzepatide activates both GLP-1 and GIP receptors. Adding GIP activation appears to produce greater weight loss in head-to-head comparisons .

What does tirzepatide do that semaglutide does not?

Tirzepatide also activates the GIP receptor, which may enhance fat metabolism and amplify the appetite-reducing effects of GLP-1. This dual mechanism is what makes tirzepatide a genuinely different drug, not just a higher dose.

Important Note

This page is for education only. It is not medical advice. Tirzepatide, whether sold as Mounjaro or Zepbound, is a prescription medication with real side effects including nausea, GI discomfort, and rare but serious risks. Do not start or adjust your dose without guidance from a licensed healthcare provider.

Built by medical professionals, gym rats, and experienced biohackers

Managing a weekly tirzepatide titration? DoseVault helps you track every dose step, log how you are feeling, and build a clear record of your progress.